Articles | Volume 9, issue 3
https://doi.org/10.5194/jbji-9-167-2024
© Author(s) 2024. This work is distributed under
the Creative Commons Attribution 4.0 License.
the Creative Commons Attribution 4.0 License.
https://doi.org/10.5194/jbji-9-167-2024
© Author(s) 2024. This work is distributed under
the Creative Commons Attribution 4.0 License.
the Creative Commons Attribution 4.0 License.
Ureaplasma urealyticum osteomyelitis of the greater trochanter in a patient with multiple sclerosis using ocrelizumab – a case report
Fred Ruythooren
CORRESPONDING AUTHOR
Department of Orthopaedic Surgery, University Hospitals Leuven – Gasthuisberg, Leuven, Belgium
Institute for Orthopaedic Research and Training (IORT), University Hospitals Leuven – Gasthuisberg, Leuven, Belgium
Stijn Ghijselings
Department of Orthopaedic Surgery, University Hospitals Leuven – Gasthuisberg, Leuven, Belgium
Institute for Orthopaedic Research and Training (IORT), University Hospitals Leuven – Gasthuisberg, Leuven, Belgium
Melissa Depypere
Department of Laboratory Medicine, University Hospitals Leuven – Gasthuisberg, Leuven, Belgium
Willem-Jan Metsemakers
Department of Trauma Surgery, University Hospitals Leuven – Gasthuisberg, Leuven, Belgium
Department of Development and Regeneration, KU Leuven, Leuven, Belgium
Liesbet Henckaerts
Department of Microbiology, Immunology and Transplantation, Laboratory for Clinical Infectious and Inflammatory Disorders, KU Leuven, Leuven, Belgium
Department of General Internal Medicine, University Hospitals Leuven – Gasthuisberg, Leuven, Belgium
Nathalie Noppe
Department of Radiology, University Hospitals Leuven – Gasthuisberg, Leuven, Belgium
Georges Vles
CORRESPONDING AUTHOR
Department of Orthopaedic Surgery, University Hospitals Leuven – Gasthuisberg, Leuven, Belgium
Institute for Orthopaedic Research and Training (IORT), University Hospitals Leuven – Gasthuisberg, Leuven, Belgium
Related authors
Jordi Cools, Stijn Ghijselings, Fred Ruythooren, Sander Jentjens, Nathalie Noppe, Willem-Jan Metsemakers, and Georges Vles
J. Bone Joint Infect., 9, 27–35, https://doi.org/10.5194/jbji-9-27-2024, https://doi.org/10.5194/jbji-9-27-2024, 2024
Short summary
Short summary
Septic arthritis (SA) of the native adult hip is a rare orthopaedic emergency. To date, the role of advanced imaging has been confined to supporting or opposing diagnosis; however, implications for surgical decision-making and outcomes have not yet been established. We found that extra-articular abscesses are present in two out of three patients and require varying anatomical approaches. Therefore, we recommend routinely performing advanced imaging in all adults with SA of the native hip joint.
Fred Ruythooren, Stijn Ghijselings, Jordi Cools, Melissa Depypere, Paul De Munter, Willem-Jan Metsemakers, and Georges Vles
J. Bone Joint Infect., 8, 209–218, https://doi.org/10.5194/jbji-8-209-2023, https://doi.org/10.5194/jbji-8-209-2023, 2023
Short summary
Short summary
A total of 41 patients who underwent surgical treatment for septic arthritis (SA) of the native hip were studied. We show that patients with SA of the native hip can be divided in three distinct clinical subgroups based on route of infection. Route of infection is directly related to the chance of femoral head preservation and should, therefore, be the basis for decision-making. Only patients with blood-borne infections in an undamaged hip had a reasonable chance of femoral head preservation.
Ann-Sophie Jacob, Jolien Onsea, Laura Bessems, Pauline Spoormans, Georges Vles, Willem-Jan Metsemakers, Sien Ombelet, and Melissa Depypere
J. Bone Joint Infect., 10, 317–326, https://doi.org/10.5194/jbji-10-317-2025, https://doi.org/10.5194/jbji-10-317-2025, 2025
Short summary
Short summary
Fracture-related infections (FRIs) and periprosthetic joint infections (PJIs) fail to recover pathogens, posing a diagnostic challenge and impacting treatment. This new method involves homogenising biopsies with beads to release bacteria, followed by inoculation in blood culture bottles using an automated system. This technique shows similar sensitivity to conventional methods, with improved specificity and faster pathogen detection. To date, no other studies have reported an optimized method for incubating biopsies from patients with FRIs.
Irene K. Sigmund, Marjan Wouthuyzen-Bakker, Tristan Ferry, Willem-Jan Metsemakers, Martin Clauss, Alex Soriano, Rihard Trebse, and Ricardo Sousa
J. Bone Joint Infect., 10, 139–142, https://doi.org/10.5194/jbji-10-139-2025, https://doi.org/10.5194/jbji-10-139-2025, 2025
Short summary
Short summary
This is a summary of our position paper on debridement, antimicrobial therapy, and implant retention (DAIR) procedures as a curative treatment strategy for acute periprosthetic hip and knee infections. It includes the defined indications as well as the contraindications of DAIR procedures when eradication/cure is intended, based on the currently available literature.
Irene K. Sigmund, Tristan Ferry, Ricardo Sousa, Alex Soriano, Willem-Jan Metsemakers, Martin Clauss, Rihard Trebse, and Marjan Wouthuyzen-Bakker
J. Bone Joint Infect., 10, 101–138, https://doi.org/10.5194/jbji-10-101-2025, https://doi.org/10.5194/jbji-10-101-2025, 2025
Short summary
Short summary
In this paper, we discuss the most relevant factors influencing the outcome and define indications, contraindications, and risk factors of a DAIR procedure based on the currently available literature. Furthermore, we discuss the surgical technique in combination with systemic antimicrobial therapy in patients undergoing a DAIR procedure.
Baixing Chen, T. Fintan Moriarty, Hans Steenackers, Georges F. Vles, Jolien Onsea, Thijs Vackier, Isabel Spriet, Rob Lavigne, R. Geoff Richards, and Willem-Jan Metsemakers
J. Bone Joint Infect., 9, 249–260, https://doi.org/10.5194/jbji-9-249-2024, https://doi.org/10.5194/jbji-9-249-2024, 2024
Short summary
Short summary
Our research explores natural antimicrobials to combat orthopedic-device-related infections, a challenging issue due to antibiotic resistance. We reviewed agents from bacteria, fungi, viruses, animals, plants and minerals, evaluating their effectiveness and synergy with traditional antibiotics. Our findings suggest these natural alternatives could revolutionize infection management in orthopedic patients, offering new hope for reducing antibiotic resistance and improving treatment outcomes.
Jordi Cools, Stijn Ghijselings, Fred Ruythooren, Sander Jentjens, Nathalie Noppe, Willem-Jan Metsemakers, and Georges Vles
J. Bone Joint Infect., 9, 27–35, https://doi.org/10.5194/jbji-9-27-2024, https://doi.org/10.5194/jbji-9-27-2024, 2024
Short summary
Short summary
Septic arthritis (SA) of the native adult hip is a rare orthopaedic emergency. To date, the role of advanced imaging has been confined to supporting or opposing diagnosis; however, implications for surgical decision-making and outcomes have not yet been established. We found that extra-articular abscesses are present in two out of three patients and require varying anatomical approaches. Therefore, we recommend routinely performing advanced imaging in all adults with SA of the native hip joint.
Fred Ruythooren, Stijn Ghijselings, Jordi Cools, Melissa Depypere, Paul De Munter, Willem-Jan Metsemakers, and Georges Vles
J. Bone Joint Infect., 8, 209–218, https://doi.org/10.5194/jbji-8-209-2023, https://doi.org/10.5194/jbji-8-209-2023, 2023
Short summary
Short summary
A total of 41 patients who underwent surgical treatment for septic arthritis (SA) of the native hip were studied. We show that patients with SA of the native hip can be divided in three distinct clinical subgroups based on route of infection. Route of infection is directly related to the chance of femoral head preservation and should, therefore, be the basis for decision-making. Only patients with blood-borne infections in an undamaged hip had a reasonable chance of femoral head preservation.
Niels Vanvelk, Esther M. M. Van Lieshout, Jolien Onsea, Jonathan Sliepen, Geertje Govaert, Frank F. A. IJpma, Melissa Depypere, Jamie Ferguson, Martin McNally, William T. Obremskey, Charalampos Zalavras, Michael H. J. Verhofstad, and Willem-Jan Metsemakers
J. Bone Joint Infect., 8, 133–142, https://doi.org/10.5194/jbji-8-133-2023, https://doi.org/10.5194/jbji-8-133-2023, 2023
Short summary
Short summary
This international retrospective cohort study displays the diagnostic characteristics of 609 patients who were treated for fracture-related infection (FRI). Clinical confirmatory criteria were present in 77% of patients. In the remaining patients, the decision to operatively collect deep tissue cultures had to be based on a set of suggestive criteria. The combined use of these suggestive criteria should guide treating physicians in the management pathway of FRI.
Cited articles
Cunliffe, N. A., Fergusson, S., Davidson, F., Lyon, A., and Ross, P. W.: Comparison of culture with the polymerase chain reaction for detection of Ureaplasma urealyticum in endotracheal aspirates of preterm infants, J. Med. Microbiol., 45, 27–30, https://doi.org/10.1099/00222615-45-1-27, 1996.
El Zein, S., Garvey, T., Amin, S., and Tande, A. J.: Native joint polyarticular septic arthritis secondary to disseminated Ureaplasma urealyticum infection in a patient on rituximab therapy with hypogammaglobulinemia: A Case Report, IDCases, 32, e01744, https://doi.org/10.1016/j.idcr.2023.e01744, 2023.
Fernández, J., Karau, M. J., Cunningham, S. A., Greenwood-Quaintance, K. E., and Patel, R.: Antimicrobial susceptibility and clonality of clinical Ureaplasma isolates in the United States, Antimicrob. Agents Chemother., 60, 4793–4798, https://doi.org/10.1128/AAC.00671-16, 2016.
Friberg, J.: Diagnosis of genital Mycoplasma and Ureaplasma infections, J. Reprod. Med., 30, 258–261, 1985.
Furr, P. M., Taylor-Robinson, D., and Webster, A. D.: Mycoplasmas and ureaplasmas in patients with hypogammaglobulinaemia and their role in arthritis: microbiological observations over twenty years., Ann. Rheum. Dis., 53, 183–187, https://doi.org/10.1136/ard.53.3.183, 1994.
Garzaro, M., Zhao, L.-P., De Castro, N., Mercier-Delarue, S., Camelena, F., Pereyre, S., Gardette, M., Berçot, B., Malphettes, M., Bébéar, C., Bouaziz, J.-D., Le Goff, J., Galicier, L., and Salmona, M.: Metagenomic next-generation sequencing restores the diagnosis of a rare infectious complication of B cell depletion, Eur. J. Clin. Microbiol., 41, 1269–1273, https://doi.org/10.1007/s10096-022-04484-7, 2022.
Gremark, A. and Axelsson, O.: Urogenital Ureaplasma gav invasiv infektion hos immunsupprimerad [Urogenital Ureaplasma urealyticum can cause invasive infection in immunosuppressed patients], Lakartidningen, 119, 22038, https://lakartidningen.se/klinik-och-vetenskap-1/artiklar-1/fallbeskrivning/2022/07/urogenital-ureaplasma-gav-invasiv-infektion-hos-immunsupprimerad/ (last access: 7 January 2024), 2022 (in Swedish).
Harold, R., Simon, G. L., Akselrod, H., Siegel, M. O., and Roberts, A.: Ureaplasma septic polyarthritis in a young woman with neuromyelitis optica receiving rituximab, BMJ Case Reports CP, 14, e237916, https://doi.org/10.1136/bcr-2020-237916, 2021.
Huang, F. S. and Shah, S. S.: 198 – Ureaplasma urealyticum, in: Principles and Practice of Pediatric Infectious Diseases, sixth edn., edited by: Long, S. S., Elsevier, Philadelphia, 1048–1050.e3, https://doi.org/10.1016/B978-0-323-75608-2.00198-1, 2023a.
Jhaveri, V. V. and Lasalvia, M. T.: Invasive Ureaplasma Infection in Patients Receiving Rituximab and Other Humoral Immunodeficiencies – A Case Report and Review of the Literature, Open Forum Infect. Dis., 6, ofz399, https://doi.org/10.1093/ofid/ofz399, 2019.
Kvalvik, S. A., Skarstein, I., Veddeng, A., Løland von Volkmann, H., Kvalvik, T., Torkildsen, Ø. F. G., and Ebbing, C.: An immunocompromised woman in her twenties with abdominal pain and vaginal discharge, Tidsskr. Norske Laege., 140, 16, https://doi.org/10.4045/tidsskr.20.0424, 2020.
McGinley, M. P., Moss, B. P., and Cohen, J. A.: Safety of monoclonal antibodies for the treatment of multiple sclerosis, Expert Opin. Drug Saf., 16, 89–100, https://doi.org/10.1080/14740338.2017.1250881, 2017.
Mikulska, M., Lanini, S., Gudiol, C., Drgona, L., Ippolito, G., Fernández-Ruiz, M., and Salzberger, B.: ESCMID Study Group for Infections in Compromised Hosts (ESGICH) Consensus Document on the safety of targeted and biological therapies: an infectious diseases perspective (Agents targeting lymphoid cells surface antigens [I]: CD19, CD20 and CD52), Clin. Microbiol. Infec., 24, S71–S82, https://doi.org/10.1016/j.cmi.2018.02.003, 2018.
Nelson, S., Matlow, A., Johnson, G., Th'ng, C., Dunn, M., and Quinn, P.: Detection of Ureaplasma urealyticum in Endotracheal Tube Aspirates from Neonates by PCR, J. Clin. Microbiol., 36, 1236–1239, https://doi.org/10.1128/JCM.36.5.1236-1239.1998, 1998.
Poulsen, E. E., Jensen-Fangel, S., and Rudolf, F.: Severe Ureaplasma urealyticum infection in a patient with ocrelizumab-induced hypogammaglobulinaemia, BMJ Case Reports CP, 16, e256029, https://doi.org/10.1136/bcr-2023-256029, 2023.
Roos, I., Hughes, S., McDonnell, G., Malpas, C. B., Sharmin, S., Boz, C., Alroughani, R., Ozakbas, S., Buzzard, K., Skibina, O., van der Walt, A., Butzkueven, H., Lechner-Scott, J., Kuhle, J., Terzi, M., Laureys, G., Van Hijfte, L., John, N., Grammond, P., Grand'Maison, F., Soysal, A., Jensen, A. V., Rasmussen, P. V., Svendsen, K. B., Barzinji, I., Nielsen, H. H., Sejbæk, T., Prakash, S., Stilund, M. L. M., Weglewski, A., Issa, N. M., Kant, M., Sellebjerg, F., Gray, O., Magyari, M., Kalincik, T., and MSBase Study GroupDanish MS Registry Study Group: Rituximab vs Ocrelizumab in Relapsing-Remitting Multiple Sclerosis, JAMA Neurol., 80, 789–797, https://doi.org/10.1001/jamaneurol.2023.1625, 2023.
Verhagen, I., Oudenhoven, H., van Welzen, B., and Kwok, W.-Y.: Ureaplasma parvum bacterial arthritis of the elbow in a patient with rheumatoid arthritis treated with rituximab, Rheumatology, 60, e17–e18, https://doi.org/10.1093/rheumatology/keaa358, 2021.
Waites, K. B., Katz, B., and Schelonka, R. L.: Mycoplasmas and Ureaplasmas as Neonatal Pathogens, Clin. Microbiol. Rev., 18, 757–789, https://doi.org/10.1128/CMR.18.4.757-789.2005, 2005.
Walter, N., Rupp, M., Baertl, S., and Alt, V.: The role of multidisciplinary teams in musculoskeletal infection, Bone Joint Res., 11, 6–7, https://doi.org/10.1302/2046-3758.111.BJR-2021-0498, 2022.
Wen, X., Nobakht, M. S., Yang, Y., Kouhsari, E., Hajilari, S., Shakourzadeh, M. Z., and Azizian, K.: Tetracyclines resistance in Mycoplasma and Ureaplasma urogenital isolates derived from human: a systematic review and meta-analysis, 22, 83, https://doi.org/10.1186/s12941-023-00628-5, 2023.
Wu, Y., Majidzadeh, N., Li, Y., Zafar Shakourzadeh, M., Hajilari, S., Kouhsari, E., and Azizian, K.: Trends of fluoroquinolones resistance in Mycoplasma and Ureaplasma urogenital isolates: Systematic review and meta-analysis, 36, 13–25, https://doi.org/10.1016/j.jgar.2023.11.007, 2024.
Short summary
The article examines a unique case of Ureaplasma urealyticum causing osteomyelitis in the greater trochanter of a 26-year-old male treated with ocrelizumab for multiple sclerosis. It emphasizes the necessity of a multidisciplinary approach and advanced PCR diagnostics to manage such rare opportunistic infections effectively, highlighting the challenges faced due to the immunosuppressive nature of monoclonal antibody therapies of this kind.
The article examines a unique case of Ureaplasma urealyticum causing osteomyelitis in the...